Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Search Results for "Alzheimers Disease Update"

01:50 EDT 1st August 2014 | BioPortfolio

Matching Channels

Vascular Dementia

Vascular Dementia accounts for 25% of all dementias (the second most commen cause after Alzheimers. It is the cumulative effects of many small strokes - patients often have evidence of vascular path...

Huntington's Disease

Huntington's disease is a hereditary disease caused by a defect in a single gene on Chromosome 4 that is inherited in an autosomal dominant fashion. The defect causes a part of DNA, called a CAG...

Eye disease

Gaucher's disease

Gaucher's (go-SHAYZ) disease occurs when certain harmful fatty substances accumulate to excessive levels in your liver, spleen, lungs, bone marrow and, less commonly, brain. This accumulation of...

Chikungunya disease

Matching News

Ebola virus disease, West Africa – update

In this update and subsequent ones, the terminology Ebola haemorrhagic fever will be replaced by Ebola virus disease (EVD) in line with the International Classification of Diseases (ICD-10). Therefore...

The Number of Suspected and Confirmed Cases of Ebola Climbs to 122

(Note: In this update and subsequent ones, the terminology Ebola hemorrhagic fever will be replaced by Ebola virus disease (EVD) in line with the International Classification of Diseases (ICD-10). The...

Researchers discover a “switch” in Alzheimer’s and stroke patient brains

A switch in the brain of Alzheimers and stroke patients prevents formation of new neurons.=

Mesoblast Provides Update on Clinical Programs of Prochymal for Crohn's Disease and Acute Graft Versus Host Disease

NEW YORK and MELBOURNE, Australia, April 28, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today provided an update on its clinical programs using th...

Alzheimer's market to increase from $3.6 billion in 2012 to $3.8 billion in 2019

As a result of Phase III therapy LMTX potentially entering the Alzheimer’s Disease (AD) industry in the near future, the AD market will increase slightly from $3.6 billion in 2012 to $3.8 bill...

Coronary artery disease: Detection of ischaemic heart disease in symptomatic women

The 2014 revision of the 2005 AHA consensus statement on the evaluation of women with suspected ischaemic heart disease is a major update. The authors discuss the spectrum of ischaemic heart disease a...

CDC Issues Meningococcal Disease Update

On Monday, March 10, a Drexel University student died from serogroup B meningococcal disease. The Centers for Disease Control and Prevention (CDC)’s laboratory analysis shows that the strain in...

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

Matching PubMed Articles

Melatonin and abeta, macular degeneration and alzheimers disease: same disease, different outcomes?

Aging is the common denominator and the highest risk factor for macular degeneration and Alzheimers Disease (AD). Important pathological hallmarks common to both diseases are the presence of amyloid ...

Update on the surgical management of Paget's disease.

Mammary Paget's disease is a rare form of breast neoplasm that often presents with a pruritic eczema-like rash involving the nipple-areolar complex, and is refractory to common remedies. It is often a...

Self management for patients with chronic obstructive pulmonary disease.

Self management interventions help patients with chronic obstructive pulmonary disease (COPD) acquire and practise the skills they need to carry out disease-specific medical regimens, guide changes in...

Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis.

To update the evidence for the efficacy of biological disease-modifying antirheumatic drugs (bDMARD) in patients with rheumatoid arthritis (RA) to inform the European League Against Rheumatism(EULAR)...

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis.

To update a previous systematic review assessing the efficacy of conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) in rheumatoid arthritis (RA).

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement